ILB® | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

25,637 results for “ILB®”

Trials

View all 21361 →

A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)

11 participants · First posted Oct 15, 2018

A Study to Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral Sclerosis

13 participants · First posted Aug 3, 2018

A Study of the ILB-3101 in Patients with Advanced Solid Tumors

240 participants · First posted May 23, 2024

Drugs

View all 1298 →

ILB

ILB-2101

ILB-3000

Organizations

View all 13 →

GENOMIC HEALTH, INC.

United States

Theralase Technologies Inc

Canada

Isb

News

View all 2965 →

Oslo University Hospital Launches Phase 2 Trial Comparing ILB® to Standard ALS Treatment

Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate from Innolake Biopharm

ViroGates and Sobi Expand Collaboration on suPARnostic® Diagnostic for Kineret® Treatment

Page 1 of 2564